| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/07/2009 | US20090118309 Selective antagonists of A2A adenosine receptors |
| 05/07/2009 | US20090118305 Pyridine and pyrazine derivatives - 083 |
| 05/07/2009 | US20090118304 2-heteroaryl-substituted indole derivative |
| 05/07/2009 | US20090118300 Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118295 Chemical compounds |
| 05/07/2009 | US20090118287 Organic compounds |
| 05/07/2009 | US20090118284 Novel compounds that are ERK inhibitors |
| 05/07/2009 | US20090118282 Compounds and methods for treatment of amyloid-beta-peptide related disorders |
| 05/07/2009 | US20090118281 Amino Alcohol Derivatives And Their Use As Renin Inhibitor |
| 05/07/2009 | US20090118270 Phosphodiesterase 4 inhibitors |
| 05/07/2009 | US20090118268 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
| 05/07/2009 | US20090118267 Indanes |
| 05/07/2009 | US20090118254 Histamine h3 receptor agents, preparation and therapeutic uses |
| 05/07/2009 | US20090118233 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 05/07/2009 | US20090118200 Proline bis-amide orexin receptor antagonists |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117074 Sulfonylpyrroles as Histone Deacetylase Inhibitors |
| 05/07/2009 | US20090117040 Novel pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 05/07/2009 | CA2704431A1 Cytokine inhibitors |
| 05/07/2009 | CA2704336A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | CA2704185A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
| 05/07/2009 | CA2703909A1 P2x3, receptor antagonists for treatment of pain |
| 05/07/2009 | CA2703876A1 Enantioselective process for preparing a substituted alkanoic acid |
| 05/07/2009 | CA2703767A1 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
| 05/07/2009 | CA2703240A1 Heterocyclic compound and pharmaceutical composition thereof |
| 05/07/2009 | CA2699631A1 Pyridazinone compounds and p2x7 receptor inhibitors |
| 05/07/2009 | CA2696237A1 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof |
| 05/07/2009 | CA2690976A1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/06/2009 | EP2055705A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 05/06/2009 | EP2055703A1 Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and pharmaceutical comprising the compound |
| 05/06/2009 | EP2055702A1 Anthracene-based compound and organic light emitting device employing the same |
| 05/06/2009 | EP2055303A2 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5H-benzo [5,6] cyclohepta [1,2-b] pyridine oral compositions |
| 05/06/2009 | EP2054405A1 Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same |
| 05/06/2009 | EP2054404A1 Imidazole compounds having an antiinflammatory effect |
| 05/06/2009 | EP2054403A1 Process for producing sulphoxide compounds |
| 05/06/2009 | EP2054402A1 An aminoisoquinoline thrombin inhibitor with improved bioavailability |
| 05/06/2009 | EP2054392A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha |
| 05/06/2009 | EP2054388A1 Viral polymerase inhibitors |
| 05/06/2009 | EP2054385A2 Phenyl, pyridine and quinoline derivatives |
| 05/06/2009 | EP1729774A4 Pyrrolidine compounds |
| 05/06/2009 | EP1670757B1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2009 | EP1667682A4 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 05/06/2009 | EP1648878B1 Piperidine compounds and pharmaceutical compositions containing them |
| 05/06/2009 | EP1613156B1 N-phenyl- " (4-pyridyl)- azinyl]amine derivatives as plant protection agents |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | EP1385506B1 Acylated piperidine derivates as melanocortin-4 receptor agonists |
| 05/06/2009 | EP1373265B1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 05/06/2009 | EP1272193B1 Synergistic combination therapy for treating cancer |
| 05/06/2009 | EP1268421B1 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 05/06/2009 | EP1242082B1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 05/06/2009 | CN101426788A Substituted pyrazinone derivatives for use as a medicine |
| 05/06/2009 | CN101426782A Melanocortin type 4 receptor agonist piperidinoylpyrrolidines |
| 05/06/2009 | CN101426781A CCR5 antagonists useful for treating HIV |
| 05/06/2009 | CN101426780A Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/06/2009 | CN101426779A Pesticides containing a bicyclic bisamide structure |
| 05/06/2009 | CN101426778A N-substituted-azacyclylamines as histamine-3 antagonists |
| 05/06/2009 | CN101426777A Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists |
| 05/06/2009 | CN101426772A Benzotriazine inhibitors of kinases |
| 05/06/2009 | CN101426769A Five-membered heterocyclic invertebrate pest control agents |
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN101426480A Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/06/2009 | CN101423513A Amine pyrimidine derivates, and production method thereof, and medicament composition and use |
| 05/06/2009 | CN101423497A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 05/06/2009 | CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient |
| 05/06/2009 | CN100484935C Benzimidazole-derivatives as factor Xa inhibitors |
| 05/06/2009 | CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 05/06/2009 | CN100484933C Novel pyrazine compounds, their use in preparing medicament for treating diseases correlated with serotonin |
| 05/06/2009 | CN100484924C Process for preparation of phenoxy-substituted 2-pyridone compounds |
| 05/05/2009 | US7528255 Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors |
| 05/05/2009 | US7528249 Amidating a cyclic carboxylic acid (methyl 1-[N-(3-methylbutyl)carbamoyl]cyclopentane-carboxylic acid) with an aminobenzodiazepinone (3-amino-1-methyl-5-phenyl-3H-benzoazepin-2-one) |
| 05/05/2009 | US7528165 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure |
| 05/05/2009 | US7528163 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye |
| 05/05/2009 | US7528162 such as 3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-(piperidin-1-yl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine, used as cannabinoid (CB1) receptor antagonists, for prophylaxis of psychological disorders |
| 05/05/2009 | US7528161 NF-kappaB inhibitors and uses thereof |
| 05/05/2009 | US7528156 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 05/05/2009 | US7528154 Polyarylcarboxamides useful as lipid lowering agents |
| 05/05/2009 | US7528153 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors |
| 05/05/2009 | US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells |
| 05/05/2009 | US7528151 Heterocyclic urea derivatives for the treatment of pain |
| 05/05/2009 | US7528150 Urea derivatives having vanilloid receptor antagonist activity |
| 05/05/2009 | US7528149 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia |
| 05/05/2009 | US7528143 JAK family of protein tyrosine kinases inhibitors; N4-(4-Methoxy-phenyl)-N2-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-pyrimidine-2,4-diamine; angiogenic-associated disorders including solid tumors and cancer, eye disease, inflammation, psoriasis, viral infection; antiproliferative agents |
| 05/05/2009 | US7528137 Compounds, compositions, and methods |
| 05/05/2009 | US7528136 Prolinamide derivatives as NK3 antagonists |
| 05/05/2009 | US7528134 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 05/05/2009 | US7528129 CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| 05/05/2009 | US7528121 Aurora kinases inhibitors; antiproliferative agents; specially for solid and haematological tumors; 2-[[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]-quinazolin-7-yl}oxy)propyl](ethyl)amino]ethyl dihydrogen phosphate |
| 05/05/2009 | CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 05/05/2009 | CA2417764C Highly absorbable solid preparations containing sitafloxacin and tartaric acid |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 05/05/2009 | CA2319005C 2-pyridylmethylamine derivatives useful as fungicides |
| 04/30/2009 | WO2009055548A1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 04/30/2009 | WO2009055467A2 Compounds that inhibit protease cathepsin s and hcv replication |
| 04/30/2009 | WO2009055357A1 Diazepane compounds which modulate the cb2 receptor |
| 04/30/2009 | WO2009055331A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |
| 04/30/2009 | WO2009054984A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/30/2009 | WO2009054792A1 Aminopyridine derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054791A1 Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5 |